P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
Main Authors: | Ida Hude Dragičević, Sandra Bašić-Kinda, Dino Dujmović, Ivo Radman, Barbara Dreta, Sandra Dotlić, Lea Galunić-Bilić, Margareta Dobrenić, Marko Kralik, Pavle Rončević, Igor Aurer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-10-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000890632.73921.fb |
Similar Items
-
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)
by: Ida Hude Dragičević, et al.
Published: (2024-03-01) -
P066 (0154) eBEACOPP FOR FRONT-LINE TREATMENT OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA (cHL) IN THE REAL WORLD SETTING
Published: (2018-10-01) -
P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
by: Anna Santarsieri, et al.
Published: (2022-10-01) -
T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
by: Joshua P. Entrop, et al.
Published: (2022-10-01) -
S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
by: J. P. Entrop, et al.
Published: (2022-06-01)